LeaLing Bio is an innovation-driven biotechnology company focused on developing breakthrough multi-functional T-cell engagers (TCEs) for the treatment of tumors and autoimmune diseases. With deep expertise in T-cell biology and multi-specific antibody engineering, we have built a robust pipeline of candidate therapeutics that are fully self-developed and target novel mechanisms for multiple disease indications. Our proprietary platform integrates cutting-edge immunological insights, aiming to create transformative therapies for patients with highly unmet medical needs.